← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. STE
  3. P/E History
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets

STE logoSTERIS plc (STE) P/E Ratio History

Historical price-to-earnings valuation from 1993 to 2026

Current P/E
34.5
Undervalued
5Y Avg P/E
64.4
-46% vs avg
PE Percentile
0%
Low
PEG Ratio
6.35
Expensive
TTM EPS$7.16
Price$213.68
5Y PE Range35.4 - 184.4
Earnings Yield2.90%

Loading P/E history...

STE Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
34.5vs64.4
-46%
Cheap vs History
vs. Healthcare
34.5vs22.3
+54%
Above Sector
vs. S&P 500
34.5vs25.1
+37%
Above Market
PEG Analysis
6.35
P/E ÷ EPS Growth
PEG > 2 = Expensive
Based on 63% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 8, 2026, STERIS plc (STE) trades at a price-to-earnings ratio of 34.5x, with a stock price of $213.68 and trailing twelve-month earnings per share of $7.16.

The current P/E is 46% below its 5-year average of 64.4x. Over the past five years, STE's P/E has ranged from a low of 35.4x to a high of 184.4x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, STE trades at a 54% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

The PEG ratio of 6.35 (P/E divided by 63% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.

Relative to the broader market, STE commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our STE DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

STE P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
WAT logoWATWaters Corporation
$23B32.66.29+0%
MMSI logoMMSIMerit Medical Systems, Inc.
$4B29.3-+5%
HSIC logoHSICHenry Schein, Inc.
$8B21.66.84+7%
CNMD logoCNMDCONMED Corporation
$1B25.20.69Best-65%
SHC logoSHCSotera Health Company
$4B58.0-+69%Best
BDX logoBDXBecton, Dickinson and Company
$56B26.31.59-1%
GEHC logoGEHCGE HealthCare Technologies Inc.
$28B13.5Lowest-+5%
MMM logoMMM3M Company
$75B24.0--21%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

STE Historical P/E Data (1993–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2026 Q3Wed Dec 31 2025 00:00:00 GM$253.52$7.1735.4x-32%
FY2026 Q2$247.44$6.9635.6x-31%
FY2026 Q1Mon Jun 30 2025 00:00:00 GM$240.22$6.5336.8x-29%
FY2025 Q4Mon Mar 31 2025 00:00:00 GM$226.65$6.2036.6x-29%
FY2025 Q3$205.56$4.7143.7x-16%
FY2025 Q2Mon Sep 30 2024 00:00:00 GM$242.54$4.3855.4x+7%
FY2025 Q1Sun Jun 30 2024 00:00:00 GM$219.54$4.0354.5x+5%
FY2024 Q4Sun Mar 31 2024 00:00:00 GM$224.82$3.8258.9x+14%
FY2024 Q3Sun Dec 31 2023 00:00:00 GM$219.85$5.7138.5x-26%
FY2024 Q2Sat Sep 30 2023 00:00:00 GM$219.42$5.5339.7x-23%
FY2024 Q1Fri Jun 30 2023 00:00:00 GM$224.98$1.22184.4x+257%
FY2023 Q4Fri Mar 31 2023 00:00:00 GM$191.28$1.07178.8x+246%

Average P/E for displayed period: 51.7x

Full STE Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

See STE's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is STE Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare STE vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

STE — Frequently Asked Questions

Quick answers to the most common questions about buying STE stock.

Is STE stock overvalued or undervalued?

STE trades at 34.5x P/E, below its 5-year average of 64.4x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.

How does STE's valuation compare to peers?

STERIS plc P/E of 34.5x compares to sector median of 22.3x. The premium reflects expected growth above peers.

What is STE's PEG ratio?

STE PEG ratio is 6.35. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1993-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

STE P/E Ratio History (1993–2026)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.